This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Greif (GEF) Hikes CRB & URB Prices to Counter Rising Costs
by Zacks Equity Research
In order to sustain margins, Greif (GEF) announces price hikes for coated recycled paperboard and uncoated recycled paperboard in the wake of rising input costs.
Sonoco (SON) Announces Price Hikes to Counter Rising Costs
by Zacks Equity Research
Sonoco (SON) announces price hikes for paperboard tubes and cores, and uncoated recycled paperboard to recover from rising input costs to sustain margins.
Coronavirus-Hit US Manufacturing Suffers Worst Drop in 74 Years
by Madhurima Das
Total industrial production and manufacturing output in the United States posted the worst drop in 74 years primarily due to the coronavirus induced crisis.
Will Sharps Compliance (SMED) Report Negative Q3 Earnings? What You Should Know
by Zacks Equity Research
Sharps Compliance (SMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lindsay Bets on Foundation for Growth Strategy Amid Headwinds
by Zacks Equity Research
Lindsay (LNN) is poised well on its successful Foundation for Growth initiative, strong demand for Road Zipper projects and transportation safety products despite the impact of the coronavirus outbreak.
O-I Glass Withdraws '20 Guidance on Coronavirus Concerns
by Zacks Equity Research
O-I Glass (OI) expects first-quarter earnings to come in at the lower-end of previously reported guidance range. However, it revokes full-year guidance.
Rockwell Automation to Cut Costs to Fight Coronavirus Woes
by Zacks Equity Research
Rockwell Automation (ROK) announces plans to cut costs to mitigate the impact of weak demand thanks to the coronavirus outbreak.
The Zacks Analyst Blog Highlights: DHT, Summit Therapeutics, Sharps Compliance, Frontline and Kala Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: DHT, Summit Therapeutics, Sharps Compliance, Frontline and Kala Pharmaceuticals
Lindsay's (LNN) Q2 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Lindsay (LNN) reports better-than-expected earnings for second-quarter fiscal 2020, aided by the Foundation for Growth initiative and an improved infrastructure business.
5 Stocks Up on Signs of Slowdown in Coronavirus Cases
by Zacks Equity Research
Coronavirus shows signs of slowdown in the United States and some other countries. While investors look for positive developments in the stock market, here are five must-buy stocks poised to grow.
Reasons to Hold Dover (DOV) Stock in Your Portfolio for Now
by Zacks Equity Research
Dover (DOV) is worth retaining in the portfolio at the moment, backed by encouraging outlook, robust backlog and cost-reduction initiatives.
Lincoln Electric Rides on Cost Control Despite Weak Demand
by Zacks Equity Research
Lincoln Electric's (LECO) cost management actions, which include lower work hours, less overtime, suspension of new hiring and cutting down discretionary spending, will help sustain margins.
Is Sharps Compliance (SMED) Stock Outpacing Its Industrial Products Peers This Year?
by Zacks Equity Research
Is (SMED) Outperforming Other Industrial Products Stocks This Year?
Greif (GEF) Completes Divestiture of CPG Business Unit
by Zacks Equity Research
Greif (GEF)???s divestiture of the Consumer Packaging Group unit will help deleverage balance sheet and focus on core industrial franchise and strategic growth priorities.
Packaging Corporation to Idle Paper Plant Due to Weak Demand
by Zacks Equity Research
Packaging Corporation of America (PKG) will idle operations at its paper mill in Jackson, AL in the wake of weak demand.
Industrial Stocks Withdrawing Guidance on Coronavirus Fears
by Madhurima Das
Industrial stocks are withdrawing guidances for 2020 amid the coronavirus-induced uncertainty as they cannot reasonably estimate its impact on their financial and operational results at this time.
Sonoco Rides on Cost Control, Buyouts Amid Coronavirus Fears
by Zacks Equity Research
Sonoco (SON) is well poised to benefit from focus on optimizing businesses and cost control, and acquisitions despite the coronavirus related impact.
Grainger Reduces Credit Facility to Boost Liquidity Position
by Zacks Equity Research
Grainger (GWW) opts to abate $1-billion unsecured revolving credit facility to boost liquidity position amid global economic concerns over the coronavirus outbreak.
Manitowoc (MTW) Withdraws Guidance on Coronavirus Concerns
by Zacks Equity Research
The impacts of the coronavirus outbreak on demand for Manitowoc's (MTW) products and services, and supply chain will likely get reflected in this year's results.
4 Ultra-Cheap Stocks to Abate Coronavirus-Led Investment Agony
by Shuvra Shankar Dey
We have picked stocks that trade under $10 with stellar bottom-line projections, positive estimate revisions and impressive share-price rally, indicating momentum in the mid-term.
Why Hold Strategy is Apt for Avery Dennison Stock Right Now
by Zacks Equity Research
Given its focus on pricing action, restructuring activities and stellar growth projections, Avery Dennison (AVY) stock is worth retaining in the portfolio at the moment.
Caterpillar (CAT) Withdraws Guidance on Coronavirus Concerns
by Zacks Equity Research
Caterpillar (CAT) withdraws fiscal 2020 guidance as the uncertainty of the impact of the coronavirus outbreak on its results cannot be reasonably estimated at this time.
Pentair Halts Operations, Pulls Guidance on Coronavirus Scare
by Zacks Equity Research
Pentair (PNR) suspends operations in major facilities and withdraws financial outlook.
Terex (TEX) Withdraws Guidance on Coronavirus Concerns
by Zacks Equity Research
Terex (TEX) withdraws its fiscal 2020 guidance as the uncertainty of the impact of the coronavirus outbreak on its results cannot be reasonably estimated at this time.
AptarGroup (ATR) Hurt by Cost Woes & Coronavirus Outbreak
by Zacks Equity Research
AptarGroup (ATR) expects weaker current-quarter results due to negative impact of the coronavirus pandemic.